Corteva price target raised to $72 from $70 at Oppenheimer
Oppenheimer analyst Kristen Owen raised the firm’s price target on Corteva (CTVA) to $72 from $70 and keeps an Outperform rating on the shares.
RBC Capital Sticks to Its Buy Rating for Corteva (CTVA)
In a report released yesterday, Arun Viswanathan from RBC Capital maintained a Buy rating on Corteva (CTVA – Research Report), with a price ...